Role of toll-like receptors in HMGB1 release from macrophages

Annals of the New York Academy of Sciences

Volumn 1109, Issue , 2007, Pages 58-65

  Pisetsky, David S ^a,b   Jiang, Weiwen ^b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Apoptosis; HMGB1; LPS; Macrophage; Toll like receptor

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; TOLL LIKE RECEPTOR; LIGAND;

APOPTOSIS; CONFERENCE PAPER; CYTOKINE PRODUCTION; IMMUNOSTIMULATION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NONHUMAN; PROTEIN FUNCTION; PROTEIN TRANSPORT; RECEPTOR INTRINSIC ACTIVITY; ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL DEATH; CYTOLOGY; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; SECRETION;

ANIMALS; CELL DEATH; HMGB1 PROTEIN; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MACROPHAGES; MODELS, IMMUNOLOGICAL; TOLL-LIKE RECEPTORS;

EID: 34848899295     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1398.008     Document Type: Conference Paper

References (27)

1. ANDERSSON, U., H. ERLANDSSON-HARRIS, H. YANG, et al. 2002. HMGB1 as a DNA-binding cytokine. J. Leukoc. Biol. 78: 1084-1091.
2. DUMITRIU, I.E., P. BARUAH, A.A. MANFREDI, et al. 2005. HMGB1: guiding immunity from within. Trends Immunol. 26: 381-387.
3. ERLANDSSON-HARRIS, H. & A. RAUCCI. 2006. Alarmin(g) news about danger. Workshop in innate danger signals and HMGB1. EMBO Rep. 7: 774-778.
4. BUSTIN, M. 1999. Regulation of DNA-dependent activities by the functional motifs of the high-mobility-group chromosomal proteins. Mol. Cell. Biol. 19: 5237-5246.
5. REEVES, R. 2000. Molecular biology of HMGA proteins: hub of nuclear function. Gene 277: 63-81.
6. RIEDEMANN, N.C., R.-F. GUO & P.A. WARD. 2003. Novel strategies for treatment of sepsis. Nature 9: 517-524.
7. ULLOA, L. & K.J. TRACEY. 2005. The 'cytokine profile': a code for sepsis. Trends Mol. Med. 11: 56-63.
8. WANG, H., O. BLOOM, M. ZHANG, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285: 248251.
9. ANDERSSON, U., H. WANG, K. PALMBLAD, et al. 2000. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J. Exp. Med. 192: 565-570.
10. YANG, H., M. OCHANI, J. LI, et al. 2004. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 101: 296-301.
11. PISETSKY, D.S. & W. JIANG. 2007. Mechanisms of disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis. Nat. Clin. Pract. Rheumatol. 3: 52-58.
12. BONALDI, T., F. TALAMO, P. SCAFFIDI, et al. 2003. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards section. EMBO J. 22: 5551-5560.
13. GARDELLA, S., C. ANDREI, D. FERRERA, et al. 2002. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3: 995-1001.
14. YOUN, J.H. & J.-S. SHIN. 2006. Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J. Immunol. 177: 7889-7897.
15. RENDON-MITCHEL, B., M. OCHANI, J. LI, et al. 2003. IFN-γ induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J. Immunol. 170: 3890-3897.
16. JIANG, W., J. LI, M. GALLOWITSCH-P UERTA, et al. 2005. The effects of CpG DNA on HMGB1 release by murine macrophage cell lines. J. Leukoc. Biol. 78: 930-936.
17. JIANG, W., C.F. REICH, III, D. YOU, et al. 2004. Induction of immune activation by a novel immunomodulatory oligonucleotide without thymocyte apoptosis. Biochem. Biophys. Res. Comm. 318: 60-66.
18. JIANG, W. & D.S. PISETSKY. 2006. The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide. J. Immunol. 177: 3337-3343.
19. FINK, S.L. & B.T. COOKSON. 2005. Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect. Immun. 73: 1907-1916.
20. FADOK, V.A., D.L. BRATTON & P.M. HENSON. 2001. Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences. J. Clin. Invest. 108: 957-962.
21. SCAFFIDI, P., T. MISTELL & M.E. BLANCHI. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418: 191-195.
22. ROVERE-QUERINI, P., A. CAPOBIANCO, P. SCAFFIDI, et al. 2004. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep. 5: 825-830.
23. BELL, C.W., W. JIANG, C.F. REICH, III, et al. 2006. The extracellular release of HMGB1 during apoptotic cell death. Am. J. Physiol. Cell. Physiol. 291: C1318-C1325.
24. ALIPRANTIS, A.O., R.-B. YANG, M.R. MARK, et al. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285: 736-739.
25. HÄCKER, H., C. FÜRMANN, H. WAGNER, et al. 2002. Caspase-9/-3 activation and apoptosis are induced in mouse macrophages upon ingestion and digestion of Escherichia coli bacteria. J. Immunol. 169: 3172-3179.
26. QIN, S., H. WANG, R. YUAN, et al. 2005. Role of HMGB1 in apoptosis-mediated sepsis lethality. J. Exp. Med. 203: 1637-1642.
27. SHERIFF, A., U.S. GAIPL, R.E. VOLL, et al. 2004. Apoptosis and systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 30: 505-527.